Endothelial cell activation by pore-forming structures -: Pivotal role for interleukin-1α

被引:75
作者
Saadi, S
Holzknecht, RA
Patte, CP
Platt, JL
机构
[1] Mayo Clin & Mayo Fdn, Dept Surg, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Pediat, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA
关键词
pore-forming peptides; endothelium; interleukin-1;
D O I
10.1161/01.CIR.101.15.1867
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Interaction of complement with endothelial cells (ECs) underlies the development of inflammation and coagulation in disease. Assembly of the membrane attack complex (MAC) of complement on EC membrane, like stimulation with cytokines, upregulates tissue factor and cyclooxygenase-2 but does so via the intermediary action of IL-1 alpha. We asked whether the MAC activates porcine aortic and microvascular ECs in a global manner by this mechanism and whether this mechanism is used by membrane pore-forming structures. Methods and Results-Exposure of ECs to complement caused upregulation of mRNAs for E-selectin, intracellular adhesion molecule-1, vascular cell adhesion molecule-1, I kappa-B alpha, interleukin (IL)-1 alpha, IL-1 beta, IL-8, and plasminogen activator inhibitor-1 over a period of 6 hours. The expression of these genes was not a primary response to stimulation, however, because IL-1 receptor antagonist inhibited expression of these genes. Activation of ECs by complement depended on the autocrine action of IL-1 alpha, because complement-mediated EC activation was inhibited by anti-IL-1 alpha antibodies. Melittin and mastoparan, amphiphilic pore-forming peptides like the MAC, induced E-selectin through intermediary action of IL-1. Conclusions-These findings suggest that transmembrane pore-forming proteins, as a class of molecules, activate ECs through the autocrine effects of IL-1 alpha.
引用
收藏
页码:1867 / 1873
页数:7
相关论文
共 35 条
[1]   REGULATION OF THE FIBRINOLYTIC SYSTEM OF CULTURED HUMAN VASCULAR ENDOTHELIUM BY INTERLEUKIN-1 [J].
BEVILACQUA, MP ;
SCHLEEF, RR ;
GIMBRONE, MA ;
LOSKUTOFF, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (02) :587-591
[2]   INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
COTRAN, RS ;
GIMBRONE, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :618-623
[3]   IDENTIFICATION OF AN INDUCIBLE ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE [J].
BEVILACQUA, MP ;
POBER, JS ;
MENDRICK, DL ;
COTRAN, RS ;
GIMBRONE, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) :9238-9242
[4]  
BROZE GJ, 1995, THROMB HAEMOSTASIS, V74, P90
[5]   Modulation of eicosanoid metabolism in endothelial cells in a xenograft model - Role of cyclooxygenase-2 [J].
Bustos, M ;
Coffman, TM ;
Saadi, S ;
Platt, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :1150-1158
[6]  
Byrne G, 1996, TRANSPLANT P, V28, P759
[7]   Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage [J].
Byrne, G ;
McCurry, KR ;
Martin, MJ ;
McClellan, SM ;
Platt, JL ;
Logan, JS .
TRANSPLANTATION, 1997, 63 (01) :149-155
[8]  
CARINCI V, 1992, EUR J BIOCHEM, V203, P293
[9]   TRANSCRIPTIONAL REGULATION OF ENDOTHELIAL-CELL ADHESION MOLECULES - NF-KAPPA-B AND CYTOKINE-INDUCIBLE ENHANCERS [J].
COLLINS, T ;
READ, MA ;
NEISH, AS ;
WHITLEY, MZ ;
THANOS, D ;
MANIATIS, T .
FASEB JOURNAL, 1995, 9 (10) :899-909
[10]  
ESMON CT, 1989, J BIOL CHEM, V264, P4743